nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease
|
Roberts, Peter J. |
|
2002 |
38 |
S5 |
p. S37-S38 2 p. |
artikel |
2 |
Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)
|
Demetri, George D. |
|
2002 |
38 |
S5 |
p. S52-S59 8 p. |
artikel |
3 |
Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy
|
Druker, Brian J. |
|
2002 |
38 |
S5 |
p. S70-S76 7 p. |
artikel |
4 |
Imatinib: a selective tyrosine kinase inhibitor
|
Manley, P.W. |
|
2002 |
38 |
S5 |
p. S19-S27 9 p. |
artikel |
5 |
Imatinib: the first 3 years
|
Capdeville, Renaud |
|
2002 |
38 |
S5 |
p. S77-S82 6 p. |
artikel |
6 |
Introduction
|
Joensuu, H. |
|
2002 |
38 |
S5 |
p. S1- 1 p. |
artikel |
7 |
Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts
|
Silbermann, Sandra |
|
2002 |
38 |
S5 |
p. S66-S69 4 p. |
artikel |
8 |
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
|
Miettinen, Markku |
|
2002 |
38 |
S5 |
p. S39-S51 13 p. |
artikel |
9 |
Pharmacology of imatinib (STI571)
|
Buchdunger, Elisabeth |
|
2002 |
38 |
S5 |
p. S28-S36 9 p. |
artikel |
10 |
Regulation and targets of receptor tyrosine kinases
|
Pawson, Tony |
|
2002 |
38 |
S5 |
p. S3-S10 8 p. |
artikel |
11 |
Significance of tyrosine kinases in cancer: overview
|
Andersson, Leif C. |
|
2002 |
38 |
S5 |
p. S2- 1 p. |
artikel |
12 |
Tyrosine kinases as targets for cancer therapy
|
Levitzki, Alexander |
|
2002 |
38 |
S5 |
p. S11-S18 8 p. |
artikel |
13 |
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group
|
van Oosterom, Allan T. |
|
2002 |
38 |
S5 |
p. S83-S87 5 p. |
artikel |
14 |
Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)
|
Van den Abbeele, Annick D. |
|
2002 |
38 |
S5 |
p. S60-S65 6 p. |
artikel |